You have 9 free searches left this month | to do more
Showing 1 - 25 of
66 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Not yet recruiting
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • (no location specified)
2021-11-15
Nov 15, 2021
E
Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
2022-02-01
Feb 1, 2022
U
Not yet recruiting
  • Refractory or Recurrent Solid Tumor
  • Spartalizumab in Pediatric cohort
  • +3 more
  • Angers, France
  • +8 more
2022-03-09
Mar 9, 2022
N
Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-02-24
Feb 24, 2021
N
Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
2022-01-21
Jan 21, 2022
M
Recruiting
  • Carcinoma, Renal Cell
  • New York, New York
    Columbia University Medical Center
2021-01-12
Jan 12, 2021
N
Recruiting
  • In Escalation: All Patients With Solid Tumors and Lymphoma
  • In Expansion: Melanoma
  • NIZ985 and Spartalizumab
  • Duarte, California
  • +8 more
2022-03-18
Mar 18, 2022
C
Recruiting
  • Gastric Cancer by AJCC V8 Stage
  • Resectable Carcinoma
  • perioperative treatment
  • Caen, France
    Centre François Baclesse
2021-06-28
Jun 28, 2021
N
Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
2022-03-18
Mar 18, 2022
M
Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-28
Jun 28, 2021
N
Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Spartalizumab
  • +2 more
  • Boston, Massachusetts
  • +15 more
2022-03-31
Mar 31, 2022
S
Recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
2022-04-01
Apr 1, 2022
S
Recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Spartalizumab
  • Badalona, Barcelona, Spain
  • +9 more
2021-08-13
Aug 13, 2021
N
Active, not recruiting
  • Melanoma
  • Spartalizumab
  • +4 more
  • Los Angeles, California
  • +30 more
2022-03-14
Mar 14, 2022
N
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
2021-03-02
Mar 2, 2021
P
Active, not recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
  • Boston, Massachusetts
  • +1 more
2022-04-05
Apr 5, 2022
N
Active, not recruiting
  • Triple Negative Breast Cancer (TNBC)
  • spartalizumab
  • +5 more
  • Boston, Massachusetts
  • +13 more
2022-01-26
Jan 26, 2022
N
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Boston, Massachusetts
  • +8 more
2022-02-24
Feb 24, 2022
N
Completed
  • Metastatic Colorectal Cancer
  • St Leonards, New South Wales, Australia
  • +10 more
2020-12-09
Dec 9, 2020
N
Completed
  • Nasopharyngeal Carcinoma
  • Spartalizumab
  • Investigator choice of chemotherapy
  • Marietta, Georgia
  • +17 more
2022-01-17
Jan 17, 2022